$HIMS

HIMS

Hims & Hers Health, Inc. Class A Common Stock

All takes and content in this window

As of 09-26
09-25
09-18
Schwab NetworkPublished 2026-09-18
“40% of U.S. Adults to Use GLP-1s? Raul Shah on LLY, NVO & Weight Loss "Mania"”
$HIMSBullish
HIMS is undervalued and poised for upside; its platform model captures value from any winning GLP-1 drug, and short-selling pressure will diminish as market cap grows.

I want to talk about the company "Hems & Hers Health". This is another name that is attracting a lot of attention, especially on social media. It's a volatile stock, but it seems to be in a transitional phase, and I'm interested to know your opinion on its role in this area, and your general opinion of the company .

09-16
Parkev Tatevosian, CFAPublished 2026-09-16
“Is Hims & Hers Stock a Buy Right Now in September? | HIMS Stock Analysis”
$HIMSBullish
HIMS is a buy for high-risk-tolerance long-term investors due to strong growth prospects and fair valuation.

Hims & Hers management team reiterated its longer-term guidance to investors. The management team is forecasting at least $6.5 billion in revenue by 2030 and $1.3 billion in adjusted earnings before interest, taxes, depreciation, and amortization.

But does this make Hims & Hers stock a buying opportunity for long-term investors? So, revenue of at least $6 billion by 2030 would be more than double their most recent trailing 12-month total.

In that period, Hims & Hers reported $2.6 billion in revenue. That's up from around $250 million in 2020. This has been one of the fastest-growing companies in the world.

09-01
“The Hims & Hers Australia Strategy: Why It Matters for Investors”
$HIMSBullish
HIMS is a high-growth asymmetric investment case; becoming the global healthcare demand aggregator could increase value 10-100x.

Being a leading telehealth company in the US could be a 10x, maybe even a bigger opportunity for Hims & Hers, but beating being the global telehealth company where you go to answer all your questions no matter where you are in the world is really where the massive opportunity is for healthcare and for Hims & Hers.

Older record
Showing 4 / 4 on this page
See this ticker’s full history